Cargando…
MTBHsp70-exFPR1-pulsed Dendritic Cells Enhance the Immune Response against Cervical Cancer
Cervical cancer is the most common malignancy of the female reproductive system. Dendritic cell (DC)-based immunological therapy is a novel treatment for this cancer. DCs are specialized antigen-presenting cells (APCs) in the human immune system, and they can activate the T cells used in tumor immun...
Autores principales: | Cao, Guangming, Cui, Ran, Liu, Chongdong, Zhang, Guyu, Zhang, Zhenyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856742/ https://www.ncbi.nlm.nih.gov/pubmed/31772669 http://dx.doi.org/10.7150/jca.29779 |
Ejemplares similares
-
FPR1 mediates the tumorigenicity of human cervical cancer cells
por: Cao, Guangming, et al.
Publicado: (2018) -
The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis
por: Zhang, Guyu, et al.
Publicado: (2019) -
FPR Ligands
por: Liu, Ying, et al.
Publicado: (2013) -
Ex vivo pulsed dendritic cell vaccination against cancer
por: Gu, Yang-zhuo, et al.
Publicado: (2020) -
Molecular recognition of formylpeptides and diverse agonists by the formylpeptide receptors FPR1 and FPR2
por: Zhuang, Youwen, et al.
Publicado: (2022)